Prognostic significance of several biomarkers in epithelial ovarian cancer: a meta-analysis of published studies Linjuan XuJing CaiZehua Wang Review 18 April 2013 Pages: 1257 - 1277
Anti-cancer effect of a quinoxaline derivative GK13 as a transglutaminase 2 inhibitor Seon-Hyeong LeeNayeon KimSoo-Youl Kim Original Paper 21 April 2013 Pages: 1279 - 1294
High IL-17-positive tumor immune cell infiltration is indicative for chemosensitivity of ovarian carcinoma Raoul A. DroeserUwe GüthGad Singer Original Paper 28 April 2013 Pages: 1295 - 1302
Impact of diabetes on overall and cancer-specific mortality in colorectal cancer patients Francesca BellaPamela MinicozziMilena Sant Original Paper 30 April 2013 Pages: 1303 - 1310
Prognostic impact of LDH levels in patients with relapsed/refractory seminoma Tom PowlesCaroline Bascoul-MolleviJörg Beyer Original Paper 03 May 2013 Pages: 1311 - 1316
Liver resection in selected patients with metastatic breast cancer: a single-centre analysis and review of literature Y. DittmarA. Altendorf-HofmannU. Settmacher Original Paper 04 May 2013 Pages: 1317 - 1325
EGFR and KRAS mutational profiling in fresh non-small cell lung cancer (NSCLC) cells Giulia M. StellaRoberta ScabiniMichele Zorzetto Original Paper 05 May 2013 Pages: 1327 - 1335
The Austrian experience with trabectedin in non-selected patients with metastatic soft tissue sarcoma (STS) F. PlonerW. LammT. Brodowicz Original Paper 11 May 2013 Pages: 1337 - 1342
Transarterial chemoembolization for pain relief in patients with hypervascular painful metastatic spinal tumors refractory to percutaneous vertebroplasty Yi ChenZhiping YanJianjun Luo Original Paper 16 May 2013 Pages: 1343 - 1348
Tuberin and p27 expression in breast cancer patients with or without BRCA germline mutations Anne Catharina DresslerGernot HudelistChristian F. Singer Original Paper 21 May 2013 Pages: 1349 - 1355
Tandem therapy for retinoblastoma: immunotherapy and chemotherapy enhance cytotoxicity on retinoblastoma by increasing apoptosis Qiuling LiuYafeng WangPatricia Elena Kunda Original Paper 21 May 2013 Pages: 1357 - 1372
Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival Ferhat OzdenCaner SayginHilal Aki Original Paper 25 May 2013 Pages: 1373 - 1382
Progression-free survival and post-progression survival in patients with advanced gastric cancer treated with first-line chemotherapy Kohei ShitaraKeitaro MatsuoAtsushi Ohtsu Original Paper 25 May 2013 Pages: 1383 - 1389
EGFR L2 domain mutation is not correlated with resistance to cetuximab in metastatic colorectal cancer patients Yuriko ItoYasuhide YamadaYasuhiro Shimada Original Paper 31 May 2013 Pages: 1391 - 1396
Lack of association of platelet-derived growth factor (PDGF) receptor autoantibodies and severity of chronic graft-versus-host disease (GvHD) Baerbel Spies-WeisshartKristina SchillingSebastian Scholl Original Paper 01 June 2013 Pages: 1397 - 1404
Association between genetic variants in pre-miRNA and colorectal cancer risk in a Chinese population Meili LvWei DongLin Zhang Original Paper 02 June 2013 Pages: 1405 - 1410
Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff? P. GazzanigaC. RaimondiE. Cortesi Original Paper 05 June 2013 Pages: 1411 - 1416
A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis Cheng XuZhehui YanYuming Wang Original Paper 07 June 2013 Pages: 1417 - 1424
Cilengitide response in ultra-low passage glioblastoma cell lines: relation to molecular markers Christina S. MullinsJulia SchubertCarl F. Classen Original Paper 08 June 2013 Pages: 1425 - 1431